Unichem acquires 20% equity stake in API & intermediate business of Optimus - Feedback

Unichem Laboratories (Unichem), a Rs. 670 crore pharma major, has entered into an agreement to acquire 20% equity stake in the API and intermediate business of Hyderabad based Optimus group (Optimus).

The transaction will give Unichem access to Optimus’ US FDA approved API manufacturing facilities, and at the same time, Optimus will gain from the extensive knowledge base and industry best practices of Unichem, making the deal a win-win for both Unichem and Optimus.Trans-Continental Capital Advisors Private Limited (TCCA) and Genesis Management Consultancy Services Private Limited (GMCS) acted as financial advisors to the transaction. TCCA, a Mumbai based advisory firm has recently acted as an advisor in the Rs. 500 crore worth acquisition of Kimplas Piping Systems by Germany’s Norma group.


About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *